Patient uses Claude AI to interpret medical data and navigate brain cancer treatment

A Reddit user shared their experience using Claude AI to navigate complex medical treatment for brain cancer. The patient, a 27-year-old Russian speaker receiving treatment in Shanghai, has primary mediastinal B-cell lymphoma with CNS involvement (brain tumor) and communicates with their medical team in Mandarin.

Daily Claude Usage for Medical Analysis

The patient uses Claude daily for several specific medical tasks:

• Interpreting immunohistochemistry panels including CD19, CD20, CD22, Ki67, and FISH results to understand prognosis implications
• Analyzing PET-CT scan results and comparing them across different treatment stages
• Evaluating CAR-T clinical trial data to understand chances with different protocols
• Understanding drug mechanisms and side effects in plain language
• Preparing informed questions for doctors before medical rounds
• Navigating medical decisions where incorrect choices could be fatal

Treatment Context and Specific Findings

The patient completed Phase 1 treatment consisting of 6 cycles of DA-EPOCH-R + nivolumab with stem cell collection. Their tumor biology shows favorable characteristics: clean FISH results, normal TP53, and three bright targets for immunotherapy. Phase 2 involves autologous stem cell transplant + dual CAR-T therapy, with good prospects for full remission.

Claude helped identify specific medical insights that the patient wouldn't have known to ask about, including:

• Understanding why SUVmax readings were likely inflated
• Explaining why first-line treatment worked on the mediastinal mass but couldn't reach the brain (due to pharmacokinetic barrier, not resistance)

The patient notes that while Anthropic recently launched Claude for Healthcare, they've been using Claude as a medical tool for months, describing it as "a lifeline" rather than a polished product.